Godawari Power reports superlative PAT growth
Godawari Power reports superlative PAT growth

Godawari Power reports superlative PAT growth

Amir Shaikh Article rating: 5.0

Godawari Power & Ispat’s consolidated revenue for the second quarter of FY19 came in at Rs. 804.39 crore which represent 45 per cent increase from the corresponding quarter of last year.

Equitas, Ujjivan tank in the wake of RBI letter
Equitas, Ujjivan tank in the wake of RBI letter

Equitas, Ujjivan tank in the wake of RBI letter

Bhagyashree Vivarekar Article rating: 5.0

Equitas Holdings, a microfinance company and Ujjivan Financial Services, an NBFC opened with a gap-down on Friday’s session and plunged more than 30 and 20 per cent, respectively. Investors turned cautious as RBI issued letters to these companies reminding licensing requirements. 

Q2FY19 Results: Kriti Nutrients PAT jumps 40 per cent
Q2FY19 Results: Kriti Nutrients PAT jumps 40 per cent

Q2FY19 Results: Kriti Nutrients PAT jumps 40 per cent

Nidhi Jani Article rating: 3.0

The EBITDA for the quarter rose by 24.6 per cent yoy to Rs. 7.45 crore as against Rs.  5.98 crore in the corresponding quarter last year, with a corresponding margin contraction of 6 bps. EBITDA margin for the quarter stood at 6.5 per cent.

Pondy Oxides reports impressive results, stock soars
Pondy Oxides reports impressive results, stock soars

Pondy Oxides reports impressive results, stock soars

Amir Shaikh Article rating: 3.5

The PAT for the quarter came in at Rs. 12.4 crore, yoy increase of 75.6 per cent. Due to strong operating performance and increase in other income aided this PAT growth.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 2.5

The markets on October 26, 2018 opened gap down. BSE Sensex is trading at 33,576.83, down by 113.26 points and the Nifty is trading at 10,094.30, down by 30.60 points. 

Q2FY19 Results: Impairment loss lead GMDC to negative bottomline
Q2FY19 Results: Impairment loss lead GMDC to negative bottomline

Q2FY19 Results: Impairment loss lead GMDC to negative bottomline

Nidhi Jani Article rating: 5.0

The unadjusted net loss for the quarter came in at Rs. 222 crore as against profit Rs. 113.04 crore in the corresponding quarter last year. This was mainly due to impairment loss amounting to Rs. 297.65 crore of investment in associate.

Glenmark receives ANDA approval for FS topical oil
Glenmark receives ANDA approval for FS topical oil

Glenmark receives ANDA approval for FS topical oil

Shohini Nath Article rating: 5.0

Glenmark Pharmaceuticals Inc., USA has received the final approval from the USFDA for FS topical oil. Shares of the company, however, slipped on Friday morning.

Praj Industries reports stellar performance
Praj Industries reports stellar performance

Praj Industries reports stellar performance

Amir Shaikh Article rating: 4.5

The company’s consolidated order book as on September 30, 2018 stood at Rs. 900 crore which comprised of 74 per cent from domestic orders and 26 per cent international orders.


RSS
First31663167316831693171317331743175Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR